Substitutes for Phoeclav 500mg/125mg Tablet
Substitutes can only be ordered…

2408 Substitutes
Sorted ByRelevancePrice
  • Detail
  • Novaclav 625 Tablet
    6 tablets
    Cipla Ltd
    ₹ 88
    34% offMRP₹ 134.06
    save 13% more per Tablet
  • Augmentin 625 Duo Tablet
    10 tablets
    Glaxo SmithKline Pharmaceuticals Ltd
    ₹ 201.10
    10% offMRP₹ 223.42
    pay 19% more per Tablet
  • Moxikind-CV 625 Tablet
    10 tablets
    Mankind Pharma Ltd
    ₹ 139
    18% offMRP₹ 171.10
    save 17% more per Tablet
  • Clavam 625 Tablet
    10 tablets
    Alkem Laboratories Ltd
    ₹ 197
    11% offMRP₹ 223.32
    pay 17% more per Tablet
  • Moxclav 625 Tablet
    10 tablets
    Sun Pharmaceutical Industries Ltd
    ₹ 154
    15% offMRP₹ 182.78
    save 9% more per Tablet
  • Moxiforce-CV 625 Tablet
    10 tablets
    Mankind Pharma Ltd
    ₹ 147
    14% offMRP₹ 171.10
    save 13% more per Tablet
  • Novamox CV 625mg Tablet
    10 tablets
    Cipla Ltd
    ₹ 165
    9% offMRP₹ 182.78
    save 2% more per Tablet
  • Mega-CV 625 Tablet
    10 tablets
    Aristo Pharmaceuticals Pvt Ltd
    ₹ 153
    13% offMRP₹ 177.42
    save 9% more per Tablet
  • Mox CV 625 Tablet
    10 tablets
    Sun Pharmaceutical Industries Ltd
    ₹ 152
    17% offMRP₹ 182.78
    save 10% more per Tablet
  • Advent 625 Tablet
    10 tablets
    Cipla Ltd
    ₹ 150
    18% offMRP₹ 182.78
    save 11% more per Tablet
  • Clamp 625 Tablet
    10 tablets
    Dr Reddy's Laboratories Ltd
    ₹ 164
    10% offMRP₹ 182.70
    save 3% more per Tablet
  • Flemiclav 625 Tablet
    10 tablets
    FDC Ltd
    ₹ 135.20
    10% offMRP₹ 150.25
    save 20% more per Tablet
  • Sensiclav 625 Tablet
    10 tablets
    Macleods Pharmaceuticals Pvt Ltd
    ₹ 140
    17% offMRP₹ 168.68
    save 17% more per Tablet
  • Hhamclav 625 Tablet
    10 tablets
    Hegde and Hegde Pharmaceutical LLP
    ₹ 201
    10% offMRP₹ 223.24
    pay 19% more per Tablet
  • Omniclav 625 Tablet
    6 tablets
    Cipla Ltd
    ₹ 93
    30% offMRP₹ 134.06
    save 8% more per Tablet
Load More